A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)
Trial details
- Registry ID
- NCT04524403
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as CORT118335
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)NCT04524403 | Corcept Therapeutics | Phase 2 | Completed | 2022-07-29Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |